HOME >> BIOLOGY >> NEWS
Richard Zare named Howard Hughes Medical Institute Professor

Richard N. Zare, chair of the Department of Chemistry at Stanford University, has been named a 2006 Howard Hughes Medical Institute Professor. Zare is one of 20 researchers from 18 universities chosen for their strong interest in improving undergraduate science education. Each recipient will receive $1 million from the Maryland-based biomedical research institute "to put their innovative ideas into action," according to an April 5 media announcement from the institute.

"The scientists whom we have selected are true pioneers--not only in their research but in their creative approaches and dedication to teaching," said Thomas R. Cech, president of the institute. "We are hopeful that their educational experiments will energize undergraduate science education throughout the nation."

In 2005, institute officials invited 100 research universities to nominate two faculty members to compete for the professorships. Of 150 applications received, 20 finalists were chosen based on the potential impact of their proposals on undergraduate science education and on the quality of their research and educational accomplishments.

"Teaching often takes a back seat to research at leading American universities," the announcement said. "Determined to change that fact, the Howard Hughes Medical Institute combed the country for leading research scientists who, through their teaching and mentoring, are striving to ignite the scientific spark in a new generation of students."

Laser technology

Zare, the Marguerite Blake Wilbur Professor in Natural Science at Stanford, has pioneered the use of laser technology to analyze chemical reactions at the molecular level. His development of laser-induced fluorescence as a technique for studying reaction dynamics has been widely adopted in other laboratories. He plans to use his institute professorship to design a new undergraduate course that applies the principles of physics, chemistry and biology to th
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
4-Apr-2006


Page: 1 2 3

Related biology news :

1. Richard Lifton awarded at WCN 2007
2. AACRs Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller
3. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
4. Richard Zare awarded the 2005 Wolf Prize in chemistry
5. HHMI researchers Richard Axel and Linda Buck win 2004 Nobel Prize
6. ChemGenex reports successful personalized dosing of Quinamed at ASCO
7. 2 UCSD physician-scientists named to Association of American Physicians
8. Osborn named Guyton Teacher of the Year by APS
9. St. Jude named a Center of Excellence in flu research
10. Newly discovered fish named after New York aquarium biologist
11. Venomous cone snail biologist named to Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/12/2019)... ... April 11, 2019 , ... Neal O’Farrell is one of the first ... He is executive director of the consumer advocacy non-profit the Identity Theft Council as ... member of the Federal Communications Commission’s Cybersecurity Roundtable and is currently a fellow of ...
(Date:4/5/2019)... AUBURN, Mass. (PRWEB) , ... April 04, 2019 ... ... family is available with integrated linear encoders providing 0.05 microns and 0.005 microns ... prices. Many motor and drive variations are available, from fast DC-servo motors with ...
(Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... ... the capacity of life sciences organizations to accelerate innovation and maximize productivity, announces ... in the past 12 months. , USDM’s Cloud Assurance is a ...
(Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
(Date:3/29/2019)... ... March 28, 2019 , ... ... testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s ... million, which is on top of the $1.7 million already awarded by CARB-X. ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... sample collection, and analysis to a team of researchers at Nnamdi Azikiwe University ... by Dr. Nneka R. Agbokoba, PhD, of the Department of Medical Laboratory Sciences ...
Breaking Biology Technology:
Cached News: